Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient who submitted a written informed consent for the this trial, and 18 \~ 90 years old~* Patient who have pancreatic cancer and/or biliary cancer with mid or distal CBD invasion~* Patient who is inoperable and/or unresectable cases of malignant pancreatic stenosis~* Patient who is attempting of endoscopic biliary metallic stenting (by ERBD) firstly~* Patient who have life expectancy at least longer than 3 months (Karnofsky score \>60%)~Exclusion Criteria:~* Patient who previously had surgical biliary drainage~* Patient who carrying bleeding disorder~* Patient who have combined Hilar and/or intra-hepatic duct cancer~* Patient who is improper to endoscopic treatment

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Paclitaxel Eluting Covered Metal Stent (Type: EXPERIMENTAL): None
- Covered Metal Stent (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).